Gene Editing Has Already Reached the Farm
While headlines about CRISPR tend to focus on human medicine, the technology is quietly transforming agriculture. Gene-edited crops are being grown commercially, gene-edited foods are on store shelves, and regulatory agencies around the world are grappling with how to classify them. Unlike the decades-long controversy over genetically modified organisms (GMOs), CRISPR-edited crops are entering the market with less public resistance -- in part because the technology works differently, and in part because regulators in several countries have decided to treat them differently.
The story of CRISPR in agriculture is about more than new crop varieties. It is about food security, climate resilience, regulatory philosophy, and whether gene editing can deliver on the promise of feeding a growing world population without the environmental costs of industrial agriculture.
CRISPR vs. Traditional GMOs
The distinction between CRISPR-edited crops and traditional GMOs is technically precise and politically significant.
Traditional GMOs are created by inserting foreign DNA -- often from a different species -- into a plant's genome using methods like Agrobacterium-mediated transformation or gene guns. A classic example is Bt corn, which contains a gene from the bacterium Bacillus thuringiensis that produces an insecticidal protein. The resulting plant contains DNA that would never appear through natural breeding.
CRISPR-edited crops typically involve making targeted changes to the plant's own genes -- deleting a small section, changing a few nucleotides, or turning a gene off. No foreign DNA is introduced. The resulting plant is indistinguishable from one that could, in theory, have arisen through natural mutation or conventional breeding. The difference is that CRISPR makes the change with precision and speed, rather than relying on random mutagenesis and years of selective breeding.
This distinction matters enormously for regulation. Many countries regulate GMOs based on the process used to create them (was foreign DNA inserted?) rather than the characteristics of the final product. CRISPR-edited crops that contain no foreign DNA can, under some regulatory frameworks, be classified as non-GMO -- exempting them from the lengthy and expensive approval processes that have slowed GMO commercialization.
Gene-Edited Foods on the Market
Several CRISPR-edited food products have already reached consumers:
Sicilian Rouge High-GABA Tomato (Japan)
In 2021, the Japanese startup Sanatech Seed began selling the Sicilian Rouge tomato, the world's first CRISPR-edited food to reach consumers. The tomato was edited to accumulate higher levels of gamma-aminobutyric acid (GABA), a compound associated with relaxation and blood pressure reduction. Japan's regulatory framework treats gene-edited foods that do not contain foreign DNA as conventional foods, requiring only notification rather than the extensive safety review mandated for traditional GMOs.
Calyxt High-Oleic Soybean Oil (United States)
Calyxt (now Cibus) developed a soybean with two fatty acid desaturase genes knocked out using gene editing, producing oil with a higher oleic acid content. The resulting oil has zero trans fats and a fatty acid profile similar to olive oil, but produced at commodity soybean scale. The USDA determined in 2019 that the edited soybean did not fall under its GMO regulations because no foreign DNA was present. The oil has been sold to food service companies in the United States.
Non-Browning Mushrooms
In 2016, Penn State plant pathologist Yinong Yang used CRISPR to knock out a polyphenol oxidase gene in white button mushrooms, preventing the enzymatic browning that causes mushrooms to turn brown after harvest. The USDA confirmed that the mushroom did not require GMO regulatory review. While not yet commercially produced at scale, it demonstrated the regulatory pathway for CRISPR-edited foods in the United States.
Additional Products
Other gene-edited crops in development or early commercialization include high-fiber wheat, non-allergenic peanuts, drought-tolerant rice, disease-resistant bananas, and herbicide-tolerant canola. The pipeline is growing rapidly as the cost and complexity of CRISPR editing in plants continues to decrease.
Regulatory Differences: United States vs. European Union
The regulatory treatment of gene-edited crops is one of the starkest policy divergences between major economies.
United States
The United States has taken a product-based approach. The USDA, FDA, and EPA evaluate genetically modified organisms based on their characteristics, not the method used to create them. In 2018, the USDA issued a statement confirming that it would not regulate plants modified through gene editing if the changes could have been achieved through conventional breeding and no plant pest DNA was introduced. This effectively exempts most CRISPR-edited crops from the GMO regulatory framework.
The result is a relatively streamlined path to market. Companies can submit a "Am I Regulated?" letter to the USDA's Animal and Plant Health Inspection Service (APHIS) and receive confirmation within weeks that their edited plant is not subject to regulation.
European Union
The EU has historically taken a process-based approach, regulating organisms based on how they were created rather than what they contain. A 2018 European Court of Justice ruling determined that organisms produced through directed mutagenesis techniques (including CRISPR) fall under the EU's GMO Directive and are subject to the same regulations as traditional GMOs. This means extensive risk assessment, labeling requirements, and a political approval process that has blocked most GMO cultivation in Europe for decades.
In 2023, the European Commission proposed new rules that would deregulate certain gene-edited plants -- specifically those with changes that could occur naturally or through conventional breeding -- but the legislation has faced opposition from environmental groups and some member states. As of early 2026, the regulatory status of gene-edited crops in the EU remains in flux.
Other Countries
Japan, Argentina, Brazil, Australia, and several other countries have adopted frameworks closer to the US model, generally exempting gene-edited crops without foreign DNA from GMO regulations. This growing regulatory divergence creates trade complications: a gene-edited crop approved as non-GMO in the United States or Japan could be classified as a regulated GMO if exported to Europe.
Public Perception
Public attitudes toward gene-edited foods are nuanced and evolving. Surveys consistently show that consumers are more accepting of gene editing that modifies a plant's own genes than of transgenic GMOs that introduce foreign DNA. The "no foreign DNA" distinction resonates with public intuitions about what is natural.
However, acceptance varies by country and context. European consumers tend to be more skeptical of all forms of genetic modification than American or Asian consumers. Trust in regulatory institutions, cultural attitudes toward food, and the influence of advocacy organizations all shape public opinion.
Transparency will be critical. Companies that market gene-edited foods without clear communication about what the technology is and how it was used risk a public backlash similar to what plagued the GMO industry. The scientific community and food industry have an opportunity to build trust by being forthcoming about both the capabilities and the limitations of gene editing in agriculture.
The Food Security Imperative
The case for CRISPR in agriculture goes beyond consumer products. The world's population is projected to reach nearly 10 billion by 2050, and climate change is making agriculture more difficult. Rising temperatures, shifting rainfall patterns, emerging crop diseases, and shrinking arable land all threaten food production.
CRISPR offers tools to address these challenges at genetic speed:
- Disease resistance: Editing susceptibility genes in staple crops like wheat, rice, and cassava can protect against devastating pathogens like wheat blast and banana wilt.
- Climate resilience: Modifying genes involved in drought tolerance, heat stress response, and salt tolerance can help crops survive in conditions that are becoming more common.
- Nutritional enhancement: Editing biosynthetic pathways can increase levels of vitamins, minerals, and beneficial compounds in staple crops consumed by populations with limited dietary diversity.
- Reduced waste: Traits like non-browning and extended shelf life reduce post-harvest losses, which account for roughly one-third of all food produced globally.
Looking Ahead
CRISPR agriculture is still in its early stages. The crops on the market today are mostly first-generation products with single-trait modifications. The next wave will involve more complex edits -- stacking multiple traits, modifying regulatory networks, and engineering entirely new metabolic capabilities.
The technology is not a silver bullet for food security. It cannot solve the structural problems of food distribution, poverty, and agricultural policy that are the primary drivers of hunger. But it can give plant breeders tools that are faster, cheaper, and more precise than anything previously available. Whether those tools reach the farmers and communities that need them most will depend not on the science, but on the policies, investments, and priorities that societies choose to adopt.
Gene-edited foods are no longer a future prospect. They are here, and they are growing.
